Palatin Technologies
PTN
#10927
Rank
HK$87.54 M
Marketcap
HK$49.16
Share price
9.81%
Change (1 day)
-50.34%
Change (1 year)

EPS for Palatin Technologies (PTN)

EPS in 2023 (TTM): -HK$23.23

According to Palatin Technologies's latest financial reports the company's current EPS (TTM) is -HK$59.19. In 2022 the company made an earnings per share (EPS) of -HK$24.54 an increase over its 2021 EPS that were of -HK$28.70.

EPS history for Palatin Technologies from 1998 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-HK$23.23-5.35%
2022-HK$24.54-14.48%
2021-HK$28.7033.09%
2020-HK$21.56-161.11%
2019HK$35.28-4909.03%
2018-HK$0.73-102.88%
2017HK$25.48-143.33%
2016-HK$58.80-9.09%
2015-HK$64.683200%
2014-HK$1.96-93.33%
2013-HK$29.40-69.39%
2012-HK$96.0410.16%
2011-HK$87.19-58.04%
2010-HK$207.77-394.44%
2009HK$70.56-121.18%
2008-HK$333.22-10.53%
2007-HK$372.42-57.78%
2006-HK$882.049.76%
2005-HK$803.645.13%
2004-HK$764.44-35%
2003-HK$1,176-38.14%
2002-HK$1,901-15.65%
2001-HK$2,25418.56%
2000-HK$1,901-41.44%
1999-HK$3,247-42.88%
1998-HK$5,684

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
HK$52.41-188.54%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
HK$52.37-188.48%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
HK$55.27-193.38%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
-HK$1.80-96.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
HK$78.48-232.58%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
HK$37.87-163.97%๐Ÿ‡บ๐Ÿ‡ธ USA
GlycoMimetics
GLYC
-HK$4.08-93.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
-HK$1.72-97.09%๐Ÿ‡บ๐Ÿ‡ธ USA